ArticleCancers2024

Exploratory Study Identifies Matrix Metalloproteinase-14 and -9 as Potential Biomarkers of Regorafenib Efficacy in Metastatic Colorectal Cancer.

Mitsukuni Suenaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.